Description
While the study shows that removing key CSF components alters fibril structure, the identity and relative contributions of critical components remain undefined. This knowledge is essential for understanding physiological aggregation processes and developing therapeutic interventions.
Gap type: open_question Source paper: Formation of Condition-Dependent Alpha-Synuclein Fibril Strain in Artificial Cerebrospinal Fluid. (2026, Advanced science (Weinheim, Baden-Wurttemberg, Germany), PMID:41262012)
Resolution criteria
Resolution requires: (1) comprehensive proteomics of CSF from ≥50 AD patients vs ≥50 age-matched controls, identifying ≥5 essential molecular components that distinguish AD from other neurodegenerative conditions; (2) functional assay showing these components are necessary for disease-relevant cellular processes (e.g., neuronal survival, synaptic integrity); (3) interventional study showing adding/removing these components changes disease phenotype. Descriptive proteomics without functional follow-up is insufficient.